Show simple item record

dc.contributor.authorMathew, Anuja
dc.contributor.authorTownsley, Elizabeth
dc.contributor.authorEnnis, Francis A.
dc.date2022-08-11T08:09:09.000
dc.date.accessioned2022-08-23T16:19:17Z
dc.date.available2022-08-23T16:19:17Z
dc.date.issued2014-04-24
dc.date.submitted2017-08-04
dc.identifier.citationFuture Microbiol. 2014;9(3):411-25. doi: 10.2217/fmb.13.171. <a href="https://doi.org/10.2217/fmb.13.171">Link to article on publisher's site</a>
dc.identifier.issn1746-0913 (Linking)
dc.identifier.doi10.2217/fmb.13.171
dc.identifier.pmid24762312
dc.identifier.urihttp://hdl.handle.net/20.500.14038/35011
dc.description.abstractDengue viruses (DENV) cause significantly more human disease than any other arbovirus, with hundreds of thousands of cases leading to severe disease in thousands annually. Antibodies and T cells induced by primary infection with DENV have the potential for both positive (protective) and negative (pathological) effects during subsequent DENV infections. In this review, we summarize studies that have examined T-cell responses in humans following natural infection and vaccination. We discuss studies that support a role for T cells in protection against and those that support a role for the involvement of T cells in the pathogenesis of severe disease. The mechanisms that lead to severe disease are complex, and T-cell responses are an important component that needs to be further evaluated for the development of safe and efficacious DENV vaccines.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=24762312&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113002/
dc.subjectdengue
dc.subjectimmune response
dc.subjectimmunopathology
dc.subjectnonstructural proteins
dc.subjectprimary infection
dc.subjectsecondary infection
dc.subjectT lymphocyte
dc.subjectvaccine
dc.subjectImmunity
dc.subjectImmunology and Infectious Disease
dc.subjectImmunology of Infectious Disease
dc.subjectInfectious Disease
dc.subjectMicrobiology
dc.titleElucidating the role of T cells in protection against and pathogenesis of dengue virus infections
dc.typeJournal Article
dc.source.journaltitleFuture microbiology
dc.source.volume9
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/infdis_pp/229
dc.identifier.contextkey10542741
html.description.abstract<p>Dengue viruses (DENV) cause significantly more human disease than any other arbovirus, with hundreds of thousands of cases leading to severe disease in thousands annually. Antibodies and T cells induced by primary infection with DENV have the potential for both positive (protective) and negative (pathological) effects during subsequent DENV infections. In this review, we summarize studies that have examined T-cell responses in humans following natural infection and vaccination. We discuss studies that support a role for T cells in protection against and those that support a role for the involvement of T cells in the pathogenesis of severe disease. The mechanisms that lead to severe disease are complex, and T-cell responses are an important component that needs to be further evaluated for the development of safe and efficacious DENV vaccines.</p>
dc.identifier.submissionpathinfdis_pp/229
dc.contributor.departmentDivision of Infectious Diseases and Immunology, Department of Medicine
dc.source.pages411-25


This item appears in the following Collection(s)

Show simple item record